Anagrelide
- Product NDC
- 62135-313
- 11-digit product format
- 621350313
- Labeler code
- 62135
- Product ID
- 62135-313_13156e50-28d1-0994-e063-6394a90a16ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anagrelide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA076683
- Marketing category
- ANDA
- Marketing start
- 2005-04-18
- Substance
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS
- Active strength
- 1 mg/1
- Pharmacologic classes
- Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anagrelide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ANAGRELIDE HYDROCHLORIDE ANHYDROUS | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VNS4435G39 |
| Rxcui | 597850, 597852 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-313-60 | Anagrelide | 60 in 1 BOTTLE | CAPSULE | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-313 | ANAGRELIDE CAPSULE [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20240308_e031dfb3-56e1-4fea-95f2-c2936e2057a0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-313-60 | 62135031360 | 60 CAPSULE in 1 BOTTLE (62135-313-60) | 60 capsule | 2024-02-05 | No | No | Current |